ACAD
27.08
-1.17
-4.14%
AEMD
4.8
+0.15
+3.23%
APRI
1.24
-0.05
-3.88%
ARNA
1.4
-0.08
-5.41%
ATEC
4.85
-0.07
-1.42%
CNAT
1.96
+0.04
+2.08%
CRXM
0.17
+0.00
+0.0589%
CYTX
1.55
0.00
0.00%
DXCM
63.04
-2.44
-3.73%
GNMK
10.98
-0.26
-2.31%
HALO
11.31
-0.57
-4.80%
ILMN
122.02
-4.38
-3.47%
INNV
0.263
+0.003
+1.0769%
INO
6.97
-0.34
-4.65%
ISCO
1.31
+0.11
+9.17%
ISIS
0
0.00
0.00%
LGND
102.59
-3.28
-3.10%
LPTN
2.62
-0.06
-2.2351%
MBVX
4.06
+0.03
+0.74%
MEIP
1.54
-0.03
-1.91%
MNOV
7.58
-0.03
-0.39%
MRTX
5.35
+0.25
+4.90%
MSTX
0.083
+0.001
+1.7073%
NBIX
42.94
-2.09
-4.64%
NUVA
66.83
+0.2
+0.30%
ONCS
1.348
-0.002
-0.1778%
ONVO
3.09
-0.07
-2.22%
OREX
1.84
-0.1
-5.15%
OTIC
16.2
0.00
0.00%
QDEL
22.2
-0.03
-0.13%
RCPT
0
0.00
0.00%
RGLS
2.65
0.00
0.00%
RMD
60.34
+0.56
+0.94%
SCIE
0.002
0.00
-5.2632%
SPHS
2.74
-0.03
-1.08%
SRNE
5.2
-0.2
-3.70%
TROV
2.3
-0.2
-8.00%
VICL
2.34
+0.02
+0.86%
ZGNX
13
-0.25
-1.89%
ACAD
27.08
-1.17
-4.14%
AEMD
4.8
+0.15
+3.23%
APRI
1.24
-0.05
-3.88%
ARNA
1.4
-0.08
-5.41%
ATEC
4.85
-0.07
-1.42%
CNAT
1.96
+0.04
+2.08%
CRXM
0.17
+0.00
+0.0589%
CYTX
1.55
0.00
0.00%
DXCM
63.04
-2.44
-3.73%
GNMK
10.98
-0.26
-2.31%
HALO
11.31
-0.57
-4.80%
ILMN
122.02
-4.38
-3.47%
INNV
0.263
+0.003
+1.0769%
INO
6.97
-0.34
-4.65%
ISCO
1.31
+0.11
+9.17%
ISIS
0
0.00
0.00%
LGND
102.59
-3.28
-3.10%
LPTN
2.62
-0.06
-2.2351%
MBVX
4.06
+0.03
+0.74%
MEIP
1.54
-0.03
-1.91%
MNOV
7.58
-0.03
-0.39%
MRTX
5.35
+0.25
+4.90%
MSTX
0.083
+0.001
+1.7073%
NBIX
42.94
-2.09
-4.64%
NUVA
66.83
+0.2
+0.30%
ONCS
1.348
-0.002
-0.1778%
ONVO
3.09
-0.07
-2.22%
OREX
1.84
-0.1
-5.15%
OTIC
16.2
0.00
0.00%
QDEL
22.2
-0.03
-0.13%
RCPT
0
0.00
0.00%
RGLS
2.65
0.00
0.00%
RMD
60.34
+0.56
+0.94%
SCIE
0.002
0.00
-5.2632%
SPHS
2.74
-0.03
-1.08%
SRNE
5.2
-0.2
-3.70%
TROV
2.3
-0.2
-8.00%
VICL
2.34
+0.02
+0.86%
ZGNX
13
-0.25
-1.89%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …